Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma

NCT00822848 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: epirubicin hydrochloride
DRUG: ifosfamide
DRUG: sorafenib tosylate
OTHER: immunoenzyme technique
OTHER: immunohistochemistry staining method
OTHER: laboratory biomarker analysis
PROCEDURE: adjuvant therapy
PROCEDURE: neoadjuvant therapy
PROCEDURE: therapeutic conventional surgery
RADIATION: hypofractionated radiation therapy

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]